Celal Bayar Universitesi Hafsa Sultan Hastanesi
Manisa, Turkey
University hospital in Manisa
Uncubozköy, Celal Bayar Ünv., 45030 Yunusemre/Manisa
About Celal Bayar Universitesi Hafsa Sultan Hastanesi
"Bilim ve İnsan"
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Diskapi Teaching and Research Hospital
2
Pfizer
2
GMG Grand Medical
1
Immunic AG
1
Ipsen
1
Shire
1
Clinical Trials at Celal Bayar Universitesi Hafsa Sultan Hastanesi
During the past decade, Celal Bayar Universitesi Hafsa Sultan Hastanesi conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 4 clinical trials were completed, i.e. on
average, 57.1% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study to Assess the Pharmacokinetics of Lanthanum Carbonate, Investigate and Compare the Efficacy, Safety and Tolerability of Lanthanum Carbonate With Calcium Carbonate in Hyperphosphataemic Children and Adolescents With Chronic Kidney Disease on Dialysis
2013-02-15
2018-11-16
Completed
63
Evaluation of Safety,Pharmacokinetics and Efficacy of CAZ-AVI With Metronidazole in Children Aged 3 Months to 18 Years Old With Complicated Intra-abdominal Infections (cIAIs).
2015-08-01
2017-06-01
Completed
83
Evaluation of Safety, Pharmacokinetics and Efficacy of Ceftazidime and Avibactam (CAZ-AVI ) Compared With Cefepime in Children From 3 Months to Less Than 18 Years of Age With Complicated Urinary Tract Infections (cUTIs)
2015-09-24
2017-09-15
Completed
97
Dysport® Treatment of Urinary Incontinence in Adults Subjects With Neurogenic Detrusor Overactivity (NDO) Due to Spinal Cord Injury or Multiple Sclerosis - Study 1
2016-03-01
2019-02-14
Terminated
227
Investigation of the Transfusion Practices in Surgical Patients in Turkey
2018-04-02
2019-02-01
Completed
6,481
Study to Evaluate the Efficacy, Safety and Tolerability of IMU-838 in Patients With Relapsing Multiple Sclerosis
2022-01-12
2032-10-01
Recruiting
1,050
Retrospective Chart Review of Treataprost Added to Antibiotic Treatment in Patients With Chronic Prostatitis
2022-04-15
2023-10-15
Not yet recruiting
140
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Celal Bayar Universitesi Hafsa Sultan Hastanesi" #1 sponsor was "Diskapi Teaching and Research Hospital" with 2 trials, followed by "Pfizer" with 2 trials
sponsored, "GMG Grand Medical" with 1 trials sponsored, "Immunic AG" with 1 trials sponsored and "Ipsen"
with 1 trials sponsored. Other sponsors include -4 different institutions and
companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Celal Bayar Universitesi Hafsa Sultan Hastanesi"
#1 collaborator was "Gama CRO Tıbbi İlaç Araştırma Org.Tic.Ltd.Şti" with 1 trials as a collaborator, "PRA Health Sciences" with 1 trials as a collaborator and "Turkish Society of Anesthesiology and Reanimation" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Celal Bayar Universitesi Hafsa Sultan Hastanesi
According to Clinical.Site data, the most researched conditions in "Celal Bayar Universitesi Hafsa Sultan Hastanesi" are
"Blood Transfusion" (2 trials), "Anemia" (1 trials), "Blood Loss Anemia" (1 trials), "Blood Loss, Surgical" (1 trials) and "Chronic Kidney Disease" (1 trials). Many other conditions were trialed in "Celal Bayar Universitesi Hafsa Sultan Hastanesi" in a lesser frequency.
Clinical Trials Intervention Types at Celal Bayar Universitesi Hafsa Sultan Hastanesi
Most popular intervention types in "Celal Bayar Universitesi Hafsa Sultan Hastanesi" are "Drug" (5 trials), "Other" (2 trials), "Biological" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.
The name of intervention was led by "Blood transfusion" (2 trials), "Ceftazidime -avibactam" (2 trials), "Botulinum toxin type A" (1 trials), "Calcium Carbonate" (1 trials) and "Cefepime" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Celal Bayar Universitesi Hafsa Sultan Hastanesi
The vast majority of trials in "Celal Bayar Universitesi Hafsa Sultan Hastanesi" are
7 trials for "All" genders and 1 trials for "Male" genders.
Clinical Trials Status at Celal Bayar Universitesi Hafsa Sultan Hastanesi
Currently, there are NaN active trials in "Celal Bayar Universitesi Hafsa Sultan Hastanesi".
1 are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 5 completed trials in Celal Bayar Universitesi Hafsa Sultan Hastanesi,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Celal Bayar Universitesi Hafsa Sultan Hastanesi, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".